Literature DB >> 24946155

Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.

Cecelia A Bellcross1, Lucy A Peipins2, Frances A McCarty3, Juan L Rodriguez2, Nikki A Hawkins2, Sharon Hensley Alford4, Steven Leadbetter2.   

Abstract

BACKGROUND: Evidence shows underutilization of cancer genetics services. To explore the reasons behind this underutilization, this study evaluated characteristics of women who were referred for genetic counseling and/or had undergone BRCA1/2 testing.
METHODS: An ovarian cancer risk perception study stratified 16,720 eligible women from the Henry Ford Health System into average-, elevated-, and high-risk groups based on family history. We randomly selected 3,307 subjects and interviewed 2,524 of them (76.3% response rate).
RESULTS: Among the average-, elevated-, and high-risk groups, 2.3, 10.1, and 20.2%, respectively, reported genetic counseling referrals, and 0.8, 3.3, and 9.5%, respectively, reported having undergone BRCA testing. Personal breast cancer history, high risk, and perceived ovarian cancer risk were associated with both referral and testing. Discussion of family history with a doctor predicted counseling referral, whereas belief that family history influenced risk was the strongest BRCA testing predictor. Women perceiving their cancer risk as much higher than other women their age were twice as likely (95% confidence interval: 2.0-9.6) to report genetic counseling referral.
CONCLUSION: In a health system with ready access to cancer genetic counseling and BRCA testing, women who were at high risk underutilized these services. There were strong associations between perceived ovarian cancer risk and genetic counseling referral, and between a belief that family history influenced risk and BRCA testing.

Entities:  

Mesh:

Year:  2014        PMID: 24946155      PMCID: PMC4522900          DOI: 10.1038/gim.2014.68

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  38 in total

1.  The association between race and attitudes about predictive genetic testing.

Authors:  Nikki Peters; Abigail Rose; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-03       Impact factor: 4.254

2.  To test or not to test? Moderators of the relationship between risk perceptions and interest in predictive genetic testing.

Authors:  Shoshana Shiloh; Shiri Ilan
Journal:  J Behav Med       Date:  2005-09-30

Review 3.  Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.

Authors:  Andrea D Forman; Michael J Hall
Journal:  Breast J       Date:  2009 Sep-Oct       Impact factor: 2.431

4.  Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.

Authors:  Ellen Warner; Kimberley Hill; Petrina Causer; Donald Plewes; Roberta Jong; Martin Yaffe; William D Foulkes; Parviz Ghadirian; Henry Lynch; Fergus Couch; John Wong; Frances Wright; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

Review 5.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Laurie Hoyt Huffman; Rongwei Fu; Emily L Harris
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

Review 6.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

7.  Cancer survivors--United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-03-11       Impact factor: 17.586

8.  Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.

Authors:  Anita Caruso; Cristina Vigna; Bruna Marozzo; Fabio M Sega; Isabella Sperduti; Francesco Cognetti; Antonella Savarese
Journal:  J Exp Clin Cancer Res       Date:  2009-12-21

9.  Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.

Authors:  Susan A Sabatino; Ellen P McCarthy; Russell S Phillips; Risa B Burns
Journal:  Cancer Detect Prev       Date:  2007-11-26

10.  The role of financial factors in acceptance of clinical BRCA genetic testing.

Authors:  Shannon Kieran; Lois J Loescher; Kyung Hee Lim
Journal:  Genet Test       Date:  2007
View more
  18 in total

Review 1.  Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.

Authors:  Christina D Williams; Alyssa Jasmine Bullard; Meghan O'Leary; Reana Thomas; Thomas S Redding; Karen Goldstein
Journal:  J Racial Ethn Health Disparities       Date:  2019-04-08

2.  Persistent Underutilization of BRCA1/2 Testing Suggest the Need for New Approaches to Genetic Testing Delivery.

Authors:  Anne Marie McCarthy
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

3.  BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.

Authors:  Danielle S Chun; Brygida Berse; Vickie L Venne; Scott L DuVall; Kelly K Filipski; Michael J Kelley; Laurence J Meyer; Michael S Icardi; Julie A Lynch
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

4.  Genetic Testing May Help Reduce Breast Cancer Disparities for African American Women.

Authors:  Anne Marie McCarthy; Katrina Armstrong
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

5.  Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015.

Authors:  Sarah Knerr; Erin J A Bowles; Kathleen A Leppig; Diana S M Buist; Hongyuan Gao; Karen J Wernli
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

6.  A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.

Authors:  Kent F Hoskins; Silvia Tejeda; Ganga Vijayasiri; Ifeanyi Beverly Chukwudozie; Mylene H Remo; Hiral A Shah; Ivy E Abraham; Lara E Balay; Tara K Maga; Ericka R Searles; Veena J Korah; Alana Biggers; Melinda R Stolley; Richard B Warnecke
Journal:  Cancer       Date:  2018-10-15       Impact factor: 6.860

7.  Breast Cancer Genetics Knowledge and Testing Intentions among Nigerian Professional Women.

Authors:  Samuel O Ngene; Babatunde Adedokun; Prisca Adejumo; Olufunmilayo Olopade
Journal:  J Genet Couns       Date:  2017-12-19       Impact factor: 2.537

8.  Validation of an Efficient Screening Tool to Identify Low-Income Women at High Risk for Hereditary Breast Cancer.

Authors:  Susan L Stewart; Celia P Kaplan; Robin Lee; Galen Joseph; Leah Karliner; Jennifer Livaudais-Toman; Rena J Pasick
Journal:  Public Health Genomics       Date:  2016-10-28       Impact factor: 2.000

9.  Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system.

Authors:  Debra T Linfield; Michael B Rothberg; Elizabeth R Pfoh; Ryan Noss; Lydia Cassard; Joseph C Powers; Laura Lipold; Kathryn A Martinez
Journal:  Breast Cancer Res Treat       Date:  2022-07-16       Impact factor: 4.624

10.  Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases.

Authors:  Karin Kast; Julia Häfner; Evelin Schröck; Arne Jahn; Carmen Werner; Cornelia Meisel; Pauline Wimberger
Journal:  Breast Care (Basel)       Date:  2021-06-17       Impact factor: 2.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.